From Casetext: Smarter Legal Research

Innocoll Pharm. v. Astrazeneca PLC

United States District Court, E.D. Pennsylvania
Oct 18, 2024
Civil Action 23-3601 (E.D. Pa. Oct. 18, 2024)

Opinion

Civil Action 23-3601

10-18-2024

INNOCOLL PHARMACEUTICALS, LTD. and INNOCOLL BIOTHERAPEUTICS N.A., INC., Plaintiffs, v. ASTRAZENECA PLC, ASTRAZENECA CHINA LTD., and ASTRAZENECA INVESTMENT CHINA CO., LTD., Defendants.


ORDER

HODGE, KELLEY B., J.

AND NOW, this 18th day of October, 2024, upon consideration of Defendant's Motion to Dismiss (ECF No. 11) and Plaintiff's Response thereto (ECF No. 15), it is ORDERED that the Motion to Dismiss is GRANTED.


Summaries of

Innocoll Pharm. v. Astrazeneca PLC

United States District Court, E.D. Pennsylvania
Oct 18, 2024
Civil Action 23-3601 (E.D. Pa. Oct. 18, 2024)
Case details for

Innocoll Pharm. v. Astrazeneca PLC

Case Details

Full title:INNOCOLL PHARMACEUTICALS, LTD. and INNOCOLL BIOTHERAPEUTICS N.A., INC.…

Court:United States District Court, E.D. Pennsylvania

Date published: Oct 18, 2024

Citations

Civil Action 23-3601 (E.D. Pa. Oct. 18, 2024)